1. Home
  2. ELUT vs IXHL Comparison

ELUT vs IXHL Comparison

Compare ELUT & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELUT
  • IXHL
  • Stock Information
  • Founded
  • ELUT 2015
  • IXHL 2001
  • Country
  • ELUT United States
  • IXHL Australia
  • Employees
  • ELUT N/A
  • IXHL N/A
  • Industry
  • ELUT Medical Specialities
  • IXHL
  • Sector
  • ELUT Health Care
  • IXHL
  • Exchange
  • ELUT Nasdaq
  • IXHL Nasdaq
  • Market Cap
  • ELUT 84.3M
  • IXHL 78.7M
  • IPO Year
  • ELUT 2020
  • IXHL N/A
  • Fundamental
  • Price
  • ELUT $1.96
  • IXHL $0.88
  • Analyst Decision
  • ELUT Strong Buy
  • IXHL
  • Analyst Count
  • ELUT 2
  • IXHL 0
  • Target Price
  • ELUT $8.00
  • IXHL N/A
  • AVG Volume (30 Days)
  • ELUT 27.8K
  • IXHL 188.5M
  • Earning Date
  • ELUT 08-06-2025
  • IXHL 05-15-2025
  • Dividend Yield
  • ELUT N/A
  • IXHL N/A
  • EPS Growth
  • ELUT N/A
  • IXHL N/A
  • EPS
  • ELUT N/A
  • IXHL N/A
  • Revenue
  • ELUT $23,711,000.00
  • IXHL $98,000.00
  • Revenue This Year
  • ELUT $20.10
  • IXHL $2,538.49
  • Revenue Next Year
  • ELUT $85.89
  • IXHL $249.95
  • P/E Ratio
  • ELUT N/A
  • IXHL N/A
  • Revenue Growth
  • ELUT N/A
  • IXHL N/A
  • 52 Week Low
  • ELUT $1.61
  • IXHL $0.08
  • 52 Week High
  • ELUT $5.12
  • IXHL $3.12
  • Technical
  • Relative Strength Index (RSI)
  • ELUT 47.39
  • IXHL 57.07
  • Support Level
  • ELUT $1.82
  • IXHL $0.95
  • Resistance Level
  • ELUT $2.16
  • IXHL $1.66
  • Average True Range (ATR)
  • ELUT 0.25
  • IXHL 0.22
  • MACD
  • ELUT -0.03
  • IXHL 0.05
  • Stochastic Oscillator
  • ELUT 23.81
  • IXHL 45.95

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: